The yin and the yang of p27Kip1 as a target for cancer therapy

European Respiratory Journal

Volumn 23, Issue 5, 2004, Pages 663-664

  Eymin, Beatrice ^a   Brambilla, E ^b  

^a INSTITUT ALBERT BONNIOT   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GRADING; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CORRELATION ANALYSIS; DOWN REGULATION; DRUG TARGETING; EDITORIAL; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; LUNG ADENOCARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ENZYME INHIBITORS; HUMANS; LUNG NEOPLASMS; NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 2442447522     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00019504     Document Type: Editorial

References (9)

1. Katayose Y, Kim M, Rakkar AN, Li Z, Cowen KH, Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997; 57: 5441-5445.
2. Eymin B, Haugg M, Droin N, Sordet O, Dimanche-Boitrel MT, Solary E. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene 1999; 18: 1411-1418.
3. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice. Cell 1996; 85: 733-744.
4. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183: 10-17.
5. Masuda A, Osada H, Yatabe Y, et al. Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments. Am J Pathol 2001; 158: 87-96.
6. Ishii T, Fujishiro M, Maguda M, et al. Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells. Eur Resp J 2004; 23: 665-670.
7. Ciaprrone M, Yamamoto H, Yao Y, et al. Localization and expression of p27Kip1 in multistage colorectal carcinogenesis. Cancer Res 1998; 58: 114-122.
8. Hurteau JA, Allison BM, Brutkiewicz SA, et al. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(KIP1) in epithelial ovarian cancer. Gynecol Oncol 2001; 83: 292-298.
9. Viglietto G, Motti ML, Bruni P, et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 2002; 8: 1136-1144.